BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22539346)

  • 21. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mint proteins are required for synaptic activity-dependent amyloid precursor protein (APP) trafficking and amyloid β generation.
    Sullivan SE; Dillon GM; Sullivan JM; Ho A
    J Biol Chem; 2014 May; 289(22):15374-83. PubMed ID: 24742670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.
    Yan P; Bero AW; Cirrito JR; Xiao Q; Hu X; Wang Y; Gonzales E; Holtzman DM; Lee JM
    J Neurosci; 2009 Aug; 29(34):10706-14. PubMed ID: 19710322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactive variants of death receptor p75
    Yi C; Goh KY; Wong LW; Ramanujan A; Tanaka K; Sajikumar S; Ibáñez CF
    EMBO J; 2021 Jan; 40(2):e104450. PubMed ID: 33258176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice.
    Ou Z; Kong X; Sun X; He X; Zhang L; Gong Z; Huang J; Xu B; Long D; Li J; Li Q; Xu L; Xuan A
    Brain Behav Immun; 2018 Mar; 69():351-363. PubMed ID: 29253574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular amyloid precursor protein sorting and amyloid-β secretion are regulated by Src-mediated phosphorylation of Mint2.
    Chaufty J; Sullivan SE; Ho A
    J Neurosci; 2012 Jul; 32(28):9613-25. PubMed ID: 22787047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
    Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Denervation of the olfactory bulb leads to decreased Aβ plaque load in a transgenic mouse model of Alzheimer' s disease.
    Bibari O; Lee S; Dickson TC; Mitew S; Vickers JC; Chuah MI
    Curr Alzheimer Res; 2013 Sep; 10(7):688-96. PubMed ID: 23905998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial loss of CALM function reduces Aβ42 production and amyloid deposition in vivo.
    Kanatsu K; Hori Y; Takatori S; Watanabe T; Iwatsubo T; Tomita T
    Hum Mol Genet; 2016 Sep; 25(18):3988-3997. PubMed ID: 27466196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation.
    Tian Y; Chang JC; Greengard P; Flajolet M
    Autophagy; 2014 Apr; 10(4):694-6. PubMed ID: 24447917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clathrin assembly protein AP180 regulates the generation of amyloid-beta peptide.
    Wu F; Matsuoka Y; Mattson MP; Yao PJ
    Biochem Biophys Res Commun; 2009 Jul; 385(2):247-50. PubMed ID: 19450545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.
    Furusawa K; Takasugi T; Chiu YW; Hori Y; Tomita T; Fukuda M; Hisanaga SI
    J Biol Chem; 2019 Jul; 294(28):10886-10899. PubMed ID: 31138646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
    Thomas RS; Alsaqati M; Bice JS; Hvoslef-Eide M; Good MA; Kidd EJ
    Neuroreport; 2017 Oct; 28(15):963-968. PubMed ID: 28885485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models.
    Zheng Y; Wang Q; Xiao B; Lu Q; Wang Y; Wang X
    PLoS One; 2012; 7(6):e39035. PubMed ID: 22701746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model.
    Rice HC; Marcassa G; Chrysidou I; Horré K; Young-Pearse TL; Müller UC; Saito T; Saido TC; Vassar R; de Wit J; De Strooper B
    Mol Neurodegener; 2020 Jan; 15(1):3. PubMed ID: 31915042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.